Home > Healthcare & Medical Devices > eClinical solutions Market

eClinical solutions Market Size By Solution (Randomization and Trial Supply Management (RTSM), Clinical Data Management System (CDMS), Clinical Trial Management System (CTMS), Electronic Clinical Outcome Assessment (eCOA), Electronic Trial Master Files (ETMF), Electronic Data Capture (EDC)), By Delivery Mode (Licensed Enterprise (On-premise) solutions, Cloud-based (SAAS) solutions, Web-hosted (On-demand) solutions), By Clinical Trial Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Contract Research Organizations (CROs), Medical Device Companies, Pharma/Biotech Companies, Hospitals & Clinics), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032

  • Report ID: GMI1774
  • Published Date: Jan 2023
  • Report Format: PDF

Industry Statistics

eClinical Solutions Market size was worth more than USD 8.7 billion in 2022 and is projected to witness a 9.9% CAGR between 2023 to 2032. Outsourcing of clinical trials to contract research organizations (CROs) to influence market growth.
 


Get more details on this report - Request Free Sample PDF
 

Diversifying expertise of contract research organizations (CROs) has supported the outsourcing of clinical trials in recent years. The need for advanced medical equipment and pharmaceutical solutions has created the requirement for efficient, quick, and reliable clinical trial solutions. These trials are mostly time-consuming and need medical expertise to succeed. The Tufts Center for the Study of Drug Development states that approximately 7 out of 8 compounds that are put through clinical testing process fail.
 

Lack of knowledge about the advantages of eClinical solutions, especially among developing countries, may restrain market expansion. These solutions facilitate data exploration across various clinical studies and ensure patient safety and regulatory compliance using self-service exploratory analysis. However, the cost of upgrading eClinical software is high which is one of its biggest drawbacks. Furthermore, developing nations mostly have low disposable income with leads to reduced spending on healthcare.
 

Wide-ranging benefits of RTSM solutions to complement market progress

Get more details on this report - Request Free Sample PDF
 

eClinical solutions market share from the randomization and trial supply management (RTSM) solution segment was nearly USD 1.5 billion in 2022. Randomization and Trial Supply Management (RTSM) system is essential for randomizing participants, distributing medications, and maintaining site supplies. It offers several advantages, including removing selection bias, balancing the group in terms of numerous known and unknown prognostic or confounding variables, and serving as the foundation for statistical tests.
 

Easy customization features to complement the use of web-hosted delivery solutions

Based on the delivery mode, eClinical solutions market from the web-hosted (On-Demand) solutions segment is expected to reach over USD 11.5 billion by 2032. These solutions have gained acceptance owing to their several benefits such as simple usability, accessibility, and comparatively minimal investment requirements. Web-hosted solutions maintain client data on cloud server which can be accessible easily through the web and only requires computer hardware with internet connectivity. These solutions are also simple to customize, allowing them to be tailored as per the requirement of customer groups.
 

Large number of participants in Phase IV clinical trials to fuel the need for eClinical solution

Global eClinical Solutions Market Share, By Clinical Phase Trial, 2022 (%)

Segment

Global market share (%), 2022

Phase I

17.20%

Phase II

18.40%

Phase III

44.60%

Phase IV

19.80%

Get more details on this report - Request Free Sample PDF
 

eClinical solutions market from the Phase IV clinical trials segment is projected to surpass USD 4.5 billion by 2032. Phase IV clinical trials primarily study the long-term benefits and risks of using a drug. It checks the drug’s performance in real-life scenarios and identifies rare side effects. Also known as post-marketing surveillance study, these trials are carried out after the drug has already received approval and is readily available to the general population. The inclusion of a large number of participants in such clinical trials over a longer period will drive the need for eClinical solutions to make large volumes of data easily accessible.
 

Robust investment in medical R&D to facilitate Europe market statistics

Get more details on this report - Request Free Sample PDF
 

Europe eClinical solutions market is predicted to be worth USD 5.4 billion by 2032 attributed to the rising government support for new medical R&D. The region also holds the presence of well-known eClinical solution firms such as Medidata Solutions, Inc., Veeva Systems, and DATATRAK. These companies are forming alliances with other related firms to support the deployment of eClinical solutions.
 

Strategic partnerships to favor the development of advanced eClinical solutions

Some of the key participants in the global eClinical solutions market include Bio-optronics, Datatrak, Inc, Veeva Systems, IBM Watson Health (Merge Healthcare Inc), Signant Health (CRF Health), Oracle Corporation, Clario, Anju Software Inc (OmniComm System Inc), Acralyon, Parexel International Corporation, Ennov, OpenClinica LLC, Datacapt, Medsharing, Dassault Systemes (Medidata), Arone (Invarture Group), ALTENE Group (Axial), Multihealth Group (Clinfile), and Evamed.
 

Companies are focusing on the development of new strategies to help support clinical trials in the coming years. For instance, in January 2021, Parexel International Corporation teamed up with Signify Health to include new clinical trials and develop the latest eClinical solutions. The aim was to provide access to clinical trials to a large pool of patients and to identify pertinent social determinants of health (SDoH) to promote links between patients, resources, and caregivers.
 

Impacts of the COVID-19 pandemic on the eClinical solutions market trends

The COVID-19 pandemic forced several biopharmaceutical and medical device companies to put fresh clinical trials on hold. Many companies reduced or even stopped their R&D spending on clinical trials in comparison to pre-COVID levels because of the outbreak. This affected the outsourcing of clinical trials to CROs and caused a steep decline in revenue.
 

However, a rapid recovery was witnessed due to the emergence of new clinical trial models or techniques that use virtual trial tools such as analytically based software and data management. Many companies are inking partnership with virtual trial platform providers, eRecruitment providers, and remote monitoring solutions providers to improve their capacity to offer hybrid/distributed CT models.
 

The eClinical Solutions market research report includes in-depth coverage of the industry with estimates & forecasts in terms of revenue in USD from 2018 to 2032, for the following segments:

By Solution

  • Randomization & trial supply management (RTSM)
  • Clinical data management system (CDMS)
  • Clinical trial management system (CLMS)
  • Electronic clinical outcome assessment (eCOA)
  • Electronic trial master file (eTMF)
  • Electronic data capture
  • Others

By Delivery Mode

  • Licensed enterprise (on-premise) solution (LES)
  • Cloud-based (SAAS) solution (CBS)
  • Web-hosted (on-demand) solution (WHS)

By Clinical Trial Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By End-use

  • Contract research organization (CRO)
  • Medical device companies
  • Pharma/biotech companies
  • Hospitals & clinics
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Poland
    • Switzerland
    • Netherland
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt

 

Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Global market for eClinical solutions was valued at more than USD 8.7 billion in 2022 and is projected to witness 9.9% CAGR between 2023 and 2032.
Web-hosted (On-Demand) delivery solutions segment is expected to reach USD 11.8 billion by 2032 due to the simplified usability and accessibility of these solutions.
Europe eClinical solutions market is predicted to record USD 5.4 billion by 2032 attributed to the rising government support for new medical R&D initiatives.
Datatrak, Inc, Veeva Systems, IBM Watson Health (Merge Healthcare Inc), Oracle Corporation, Clario, and Anju Software Inc (OmniComm System Inc) are some of the key players in the eClinical solution industry.

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 19
  • Tables & Figures: 313
  • Countries covered: 25
  • Pages: 190
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount